メインコンテンツに移動

Valuation under the microscope

Hedge fund valuation is coming under more scrutiny than ever before. Kris Devasabai speaks to industry experts about best practices in this area and how the framework of the US Financial Accounting Standard Board’s classification of financial assets based on the inputs used to determine their value is affecting the industry.

cross-section-of-pine-needle-under-microscope

Hedge fund valuation has emerged as a key concern among investors and regulators worldwide. The issue reached a tipping point during the financial crisis. As markets went into meltdown many hedge funds found they were unable to liquidate their holdings at the prices communicated to investors, forcing them to recalculate their net asset values (NAVs) or suspend or gate redemptions until markets

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

無料メンバーシップの内容をお知りになりたいですか?ここをクリック

パスワードを表示
パスワードを非表示にする

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here